S Anak
Overview
Explore the profile of S Anak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, et al.
J Chemother
. 2001 Jul;
13(3):281-7.
PMID: 11450887
Infection remains the major cause of morbidity and mortality in immunocompromised children with malignancy. In addition, the economic impact of antibiotic treatment should always be evaluated, especially in developing countries....
12.
Yalman N, Sarper N, Devecioglu O, Anak S, Eryilmaz E, Can M, et al.
Turk J Pediatr
. 2000 Dec;
42(3):198-204.
PMID: 11105617
The prognosis of relapsed acute leukemia or chronic leukemia in acute blast crisis is poor and new chemotherapeutic regimens could be useful for these patients. Six relapsed acute lymphoblastic leukemia...
13.
Sarper N, Ozbek U, Agaoglu L, Ozgen U, Eryilmaz E, Yalman N, et al.
Pediatr Hematol Oncol
. 2000 Oct;
17(7):577-83.
PMID: 11033733
To assess the clinical significance of AML1/ETO gene detected by nested reverse transcriptase polymerase chain reaction, the outcome of 7 patients with acute myeloblastic leukemia between 3 and 14 years...
14.
Ozgen U, Anak S, Ozbek U, Sarper N, Eryilmaz E, Agaoglu L, et al.
Acta Haematol
. 2000 Oct;
103(4):229-30.
PMID: 11014901
No abstract available.
15.
Karakas Z, Agaoglu L, Biner B, Devecioglu O, Anak S, Yalman N, et al.
Acta Med Okayama
. 2000 Sep;
54(4):173-7.
PMID: 10985177
Fifty-one children (median age: 4.5 years; 4 months-16 years) diagnosed with rhabdomyosarcoma were treated in our center between 1980-1999. The primary sites were head and neck in 31.4%, the genito-urinary...
16.
Ilhan O, Uskent N, Arslan O, Arat M, Ozkalemkas F, Ozturk G, et al.
Transfus Sci
. 2000 Jun;
22(3):195-201.
PMID: 10831922
The Turkish Apheresis Group has maintained a national registry for apheresis activities since 1997. The hemapheresis practice of Turkey in 1998 is summarized in brief detail in this article. A...
17.
Karakas Z, Agaoglu L, Erdem S, Anak S, Hacibektasoglu A, Gedikoglu G
Adv Exp Med Biol
. 1999 Sep;
457:453-9.
PMID: 10500822
No abstract available.
18.
Karakas Z, Agaoglu L, Erdem S, Demirel G, Arasa M, Suzergoz F, et al.
Adv Exp Med Biol
. 1999 Sep;
457:21-8.
PMID: 10500776
No abstract available.
19.
Sepet E, Aytepe Z, Ozerkan A, Yalman N, Guven Y, Anak S, et al.
J Clin Pediatr Dent
. 1998 Jun;
22(3):257-60.
PMID: 9641104
The dental health of 41 children aged 4-16 years who were in maintenance therapy from acute lymphoblastic leukemia (ALL) was examined in relation to the period of time in maintenance....
20.
Ozbek U, Vural B, Kalayoglu S, Soysal T, Bilgen H, Yavuz S, et al.
Turk J Pediatr
. 1997 Jul;
39(3):303-11.
PMID: 9339108
Evaluation of chimeric status following allogenic BMT is an important tool for monitoring the replacement of host cells with donor cells and for determining the risk of relapse. Polymorphic DNA...